| Questcor Bottles Profits In Its Vials - Seeking Alpha |
|
|
Seeking Alpha The company is hoping for similar growth from its beefed up nephrology sales force. The company began selling Acthar for kidney disease earlier this year and has since increased its NS sales force from 5 to 28 people, which should drive script growth |